RadiotherapyPelvic NeoplasmsPelvisRadiotherapy, AdjuvantRadiotherapy DosageRadiation InjuriesAdjuvants, ImmunologicChemotherapy, AdjuvantCombined Modality TherapyAntidiarrhealsRectal NeoplasmsRadiotherapy, ConformalBrachytherapyFreund's AdjuvantRadiation DosageUterine Cervical NeoplasmsRadiation, IonizingDose-Response Relationship, RadiationRadiotherapy, Intensity-ModulatedTreatment OutcomeNeoplasm StagingRadiotherapy Planning, Computer-AssistedAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalCisplatinRadiation ToleranceRadiotherapy, High-EnergyRadiation OncologyDose FractionationAdenocarcinomaAdjuvants, PharmaceuticRadiationRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedNeoplasm Recurrence, LocalRadiation ProtectionBreast NeoplasmsRadiation MonitoringSurvival AnalysisRadiation PneumonitisSurvival RateFluorouracilPrognosisNeoplasms, Radiation-InducedRetrospective StudiesRadiosurgeryHead and Neck NeoplasmsRadiation-Sensitizing AgentsFollow-Up StudiesRadiometryBrain NeoplasmsChemoradiotherapyAntineoplastic AgentsTime FactorsCarcinoma, Squamous CellRadiation Injuries, ExperimentalAluminum HydroxideNasopharyngeal NeoplasmsGamma RaysParticle AcceleratorsAntineoplastic Agents, HormonalRadiation-Protective AgentsRadiodermatitisOrgans at RiskNeoadjuvant TherapyTamoxifenCyclophosphamideLymphatic MetastasisMastectomy, SegmentalLung NeoplasmsCranial IrradiationCosmic RadiationMastectomyImmunizationCobalt RadioisotopesTomography, X-Ray ComputedNeoplasmsMice, Inbred BALB CDacarbazineDoxorubicinNeoplasms, Second PrimaryKaplan-Meier EstimateVincristineBackground RadiationDrug Administration ScheduleProstatic NeoplasmsLaryngeal NeoplasmsMethotrexateHodgkin DiseaseVaccinesAdministration, IntranasalProspective StudiesCarcinoma, Non-Small-Cell LungGlioblastomaRadiobiologyCarcinomaSarcomaClinical Trials as TopicAntineoplastic Agents, AlkylatingProcarbazine